Journey Medical (DERM) Competitors $4.58 +0.03 (+0.66%) (As of 11:53 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends DERM vs. TSHA, ALMS, AKBA, CYRX, DSGN, PROC, BTMD, NGNE, VYGR, and CTNMShould you be buying Journey Medical stock or one of its competitors? The main competitors of Journey Medical include Taysha Gene Therapies (TSHA), Alumis (ALMS), Akebia Therapeutics (AKBA), Cryoport (CYRX), Design Therapeutics (DSGN), Procaps Group (PROC), biote (BTMD), Neurogene (NGNE), Voyager Therapeutics (VYGR), and Contineum Therapeutics (CTNM). These companies are all part of the "pharmaceutical products" industry. Journey Medical vs. Taysha Gene Therapies Alumis Akebia Therapeutics Cryoport Design Therapeutics Procaps Group biote Neurogene Voyager Therapeutics Contineum Therapeutics Journey Medical (NASDAQ:DERM) and Taysha Gene Therapies (NASDAQ:TSHA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, community ranking, valuation, risk, institutional ownership and earnings. Which has more volatility and risk, DERM or TSHA? Journey Medical has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500. Comparatively, Taysha Gene Therapies has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Do analysts rate DERM or TSHA? Journey Medical currently has a consensus target price of $9.38, suggesting a potential upside of 104.69%. Taysha Gene Therapies has a consensus target price of $6.63, suggesting a potential upside of 265.01%. Given Taysha Gene Therapies' higher probable upside, analysts clearly believe Taysha Gene Therapies is more favorable than Journey Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Journey Medical 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Taysha Gene Therapies 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in DERM or TSHA? 7.3% of Journey Medical shares are held by institutional investors. Comparatively, 77.7% of Taysha Gene Therapies shares are held by institutional investors. 13.2% of Journey Medical shares are held by insiders. Comparatively, 2.7% of Taysha Gene Therapies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor DERM or TSHA? In the previous week, Taysha Gene Therapies had 1 more articles in the media than Journey Medical. MarketBeat recorded 1 mentions for Taysha Gene Therapies and 0 mentions for Journey Medical. Journey Medical's average media sentiment score of 1.93 beat Taysha Gene Therapies' score of 1.79 indicating that Journey Medical is being referred to more favorably in the media. Company Overall Sentiment Journey Medical Very Positive Taysha Gene Therapies Very Positive Is DERM or TSHA more profitable? Journey Medical has a net margin of -31.74% compared to Taysha Gene Therapies' net margin of -229.67%. Taysha Gene Therapies' return on equity of -106.36% beat Journey Medical's return on equity.Company Net Margins Return on Equity Return on Assets Journey Medical-31.74% -132.10% -26.90% Taysha Gene Therapies -229.67%-106.36%-49.16% Which has higher earnings and valuation, DERM or TSHA? Journey Medical has higher revenue and earnings than Taysha Gene Therapies. Journey Medical is trading at a lower price-to-earnings ratio than Taysha Gene Therapies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJourney Medical$57.77M1.66-$3.85M-$0.94-4.87Taysha Gene Therapies$9.92M37.52-$111.57M$0.632.88 Does the MarketBeat Community believe in DERM or TSHA? Taysha Gene Therapies received 99 more outperform votes than Journey Medical when rated by MarketBeat users. However, 100.00% of users gave Journey Medical an outperform vote while only 77.04% of users gave Taysha Gene Therapies an outperform vote. CompanyUnderperformOutperformJourney MedicalOutperform Votes5100.00% Underperform VotesNo VotesTaysha Gene TherapiesOutperform Votes10477.04% Underperform Votes3122.96% SummaryJourney Medical beats Taysha Gene Therapies on 10 of the 19 factors compared between the two stocks. Ad Prosper Trading AcademyA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a dayClick HERE to access this powerful AI Trading System Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DERM vs. The Competition Export to ExcelMetricJourney MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$95.68M$6.70B$5.23B$9.25BDividend YieldN/A3.00%5.12%4.30%P/E Ratio-4.8710.6387.6217.25Price / Sales1.66195.201,167.09120.47Price / Cash28.5957.1643.2337.83Price / Book4.365.144.824.92Net Income-$3.85M$151.58M$120.46M$225.43M7 Day Performance-5.18%-1.09%-0.57%0.74%1 Month Performance-14.71%-3.43%15.69%2.37%1 Year PerformanceN/A8.66%29.92%16.58% Journey Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DERMJourney Medical2.5933 of 5 stars$4.58+0.7%$9.38+104.7%N/A$95.68M$57.77M-4.8790TSHATaysha Gene Therapies3.8948 of 5 stars$2.03-1.9%$6.63+226.4%+12.3%$416.03M$15.45M3.29180Positive NewsGap UpALMSAlumisN/A$8.63+2.9%$26.83+210.9%N/A$407.53MN/A0.00N/ALockup ExpirationPositive NewsAKBAAkebia Therapeutics3.5661 of 5 stars$1.86+0.3%$7.50+304.3%+55.5%$404.73M$169.88M-8.15167CYRXCryoport3.0542 of 5 stars$7.53-2.1%$12.50+66.0%-52.2%$372.22M$226.11M-2.321,170DSGNDesign Therapeutics0.9296 of 5 stars$6.43+14.8%$7.00+8.9%+132.6%$364.07MN/A-7.1840Positive NewsPROCProcaps Group0.9084 of 5 stars$3.21+33.2%N/A-24.6%$362.15M$414.10M5.105,500High Trading VolumeBTMDbiote2.9325 of 5 stars$6.60+3.6%$9.11+38.0%+14.9%$358.62M$193.06M24.77194NGNENeurogene3.5097 of 5 stars$24.03+2.2%$60.83+153.2%N/A$356.97M$925,000.000.0090VYGRVoyager Therapeutics4.6252 of 5 stars$6.50+3.7%$17.00+161.5%-32.4%$355.10M$250.01M8.83100CTNMContineum Therapeutics2.2358 of 5 stars$13.56-3.3%$29.25+115.7%N/A$349.58M$50M0.0031 Related Companies and Tools Related Companies Taysha Gene Therapies Competitors Alumis Competitors Akebia Therapeutics Competitors Cryoport Competitors Design Therapeutics Competitors Procaps Group Competitors biote Competitors Neurogene Competitors Voyager Therapeutics Competitors Contineum Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DERM) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DERM Stock Alerts